- Home
- INKT vs LSTA Comparison
INKT vs LSTA Comparison
Compare INKT & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- LSTA
- Stock Information
- Founded
- INKT 2017
- LSTA 1980
- Country
- INKT United States
- LSTA United States
- Employees
- INKT N/A
- LSTA N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- LSTA Misc Health and Biotechnology Services
- Sector
- INKT Health Care
- LSTA Health Care
- Exchange
- INKT Nasdaq
- LSTA Nasdaq
- Market Cap
- INKT 69.2M
- LSTA 22.3M
- IPO Year
- INKT 2021
- LSTA N/A
- Fundamental
- Price
- INKT $15.35
- LSTA $2.39
- Analyst Decision
- INKT Buy
- LSTA Strong Buy
- Analyst Count
- INKT 3
- LSTA 2
- Target Price
- INKT $37.50
- LSTA $23.50
- AVG Volume (30 Days)
- INKT 41.0K
- LSTA 21.2K
- Earning Date
- INKT 11-13-2025
- LSTA 11-11-2025
- Dividend Yield
- INKT N/A
- LSTA N/A
- EPS Growth
- INKT N/A
- LSTA N/A
- EPS
- INKT N/A
- LSTA N/A
- Revenue
- INKT N/A
- LSTA $1,070,000.00
- Revenue This Year
- INKT N/A
- LSTA N/A
- Revenue Next Year
- INKT N/A
- LSTA N/A
- P/E Ratio
- INKT N/A
- LSTA N/A
- Revenue Growth
- INKT N/A
- LSTA N/A
- 52 Week Low
- INKT $4.56
- LSTA $1.87
- 52 Week High
- INKT $76.00
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- INKT 52.36
- LSTA 51.61
- Support Level
- INKT $13.11
- LSTA $2.10
- Resistance Level
- INKT $16.20
- LSTA $2.43
- Average True Range (ATR)
- INKT 1.10
- LSTA 0.17
- MACD
- INKT 0.05
- LSTA 0.02
- Stochastic Oscillator
- INKT 72.47
- LSTA 82.05
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.